Top Versus Top: Sierra Oncology, Inc. (NASDAQ:SRRA), Goldman Sachs Group, Inc. (The) (NYSE:GS)

Sierra Oncology, Inc. (NASDAQ:SRRA)

Sierra Oncology, Inc. (NASDAQ:SRRA) closed at $0.66 on the last trading session with an increase of 0%, whereas, it previously closed at $0.66. The company has a market capitalization of $49.3 Million. The company traded shares of 897703 on the trading day while its three month average volume stands at 1.02 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Sierra Oncology, Inc. (NASDAQ:SRRA) produced diluted EPS of -0.74. The EPS estimate for next year as estimated by analysts is at -0.96 while EPS for next quarter is estimated at -0.2. Earnings per Share growth for this year is reported at -8.1, while the analysts estimated the EPS growth for next year at -0.96% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -53.6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Sierra Oncology, Inc. (NASDAQ:SRRA) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Sierra Oncology, Inc. (NASDAQ:SRRA) stands at 0 and Price to Book or P/B for the most recent quarter stands at 0.59. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Sierra Oncology, Inc. (NASDAQ:SRRA) are reported at 13.1 and 13.1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Sierra Oncology, Inc. (NASDAQ:SRRA) stands at -48.3, -54.1 and 0 respectively

The trailing twelve month Revenue of Sierra Oncology, Inc. (NASDAQ:SRRA) is reported at 0 with income of -54800000. The outstanding shares of Sierra Oncology, Inc. (NASDAQ:SRRA) are 74.7 Million. The institutional Ownership of the shares of 65.8 stands at 0.80%, this figure is decreased -1.99 in the last six months. The insider ownership for the shares of Sierra Oncology, Inc. (NASDAQ:SRRA) is ticked at 1.38%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Sierra Oncology, Inc. (NASDAQ:SRRA) is the Mean Target Price estimated by the analysts which stands at 5.67. The 52 week high of Sierra Oncology, Inc. (NASDAQ:SRRA) is placed at 3.70 and 52 week low is standing at 0.61.

Performance wise the shares of Sierra Oncology, Inc. (NASDAQ:SRRA) fell down -3.8% for the week, it also fell -56.86% for the monthly performance, while for the quarter it went up -64.52%. The shares decrease -57.96% for the half year and plummeted for the Year-To-Date performance. The shares of Sierra Oncology, Inc. (NASDAQ:SRRA) shrinked -81.3% for the yearly performance.

Goldman Sachs Group, Inc. (The) (NYSE:GS)

Goldman Sachs Group, Inc. (The) (NYSE:GS) closed at $191.66 on the last trading session with an increase of 0.11%, whereas, it previously closed at $191.45. The company has a market capitalization of $70.04 Billion. The company traded shares of 1.4 Million on the trading day while its three month average volume stands at 2.7 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Goldman Sachs Group, Inc. (The) (NYSE:GS) produced diluted EPS of 22.76. The EPS estimate for next year as estimated by analysts is at 25.84 while EPS for next quarter is estimated at 5.44. Earnings per Share growth for this year is reported at 21.5, while the analysts estimated the EPS growth for next year at 25.84% and Earnings growth for next 5 years stands at 6.1% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 9.2%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Goldman Sachs Group, Inc. (The) (NYSE:GS) is at 8.42 while the forward p/e is at 7.42. The P/S or Price to Sales ratio of Goldman Sachs Group, Inc. (The) (NYSE:GS) stands at 1.32 and Price to Book or P/B for the most recent quarter stands at 0.92. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Goldman Sachs Group, Inc. (The) (NYSE:GS) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Goldman Sachs Group, Inc. (The) (NYSE:GS) stands at 1, 12 and 1.7 respectively

The trailing twelve month Revenue of Goldman Sachs Group, Inc. (The) (NYSE:GS) is reported at 53.18 Billion with income of 8.82 Billion. The outstanding shares of Goldman Sachs Group, Inc. (The) (NYSE:GS) are 365.44 Million. The institutional Ownership of the shares of 74.6 stands at 0.80%, this figure is decreased -1.09 in the last six months. The insider ownership for the shares of Goldman Sachs Group, Inc. (The) (NYSE:GS) is ticked at 0.4%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Goldman Sachs Group, Inc. (The) (NYSE:GS) is the Mean Target Price estimated by the analysts which stands at 230.76. The 52 week high of Goldman Sachs Group, Inc. (The) (NYSE:GS) is placed at 245.08 and 52 week low is standing at 151.70.

Performance wise the shares of Goldman Sachs Group, Inc. (The) (NYSE:GS) rose up 0.97% for the week, it also fell -2.41% for the monthly performance, while for the quarter it went up -3.33%. The shares increase 8.47% for the half year and flew up for the Year-To-Date performance. The shares of Goldman Sachs Group, Inc. (The) (NYSE:GS) shrinked -18.03% for the yearly performance.

You may missed